Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: A novel therapy in prostate cancer
- 1 December 1997
- Vol. 50 (6) , 1007-1015
- https://doi.org/10.1016/s0090-4295(97)00390-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Molecular insights into altered cell cycle regulation and genitourinary malignancyUrologic Oncology: Seminars and Original Investigations, 1995
- Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype.The Journal of cell biology, 1994
- Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen miboleroneBritish Journal of Cancer, 1992
- Control of c-myc Regulation in Normal and Neoplastic CellsPublished by Elsevier ,1991
- Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretionThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Levels of c-myc oncogene mRNA are invariant throughout the cell cycleNature, 1985
- Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformationCell, 1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factorCell, 1983